Xlife Sciences AG
Research Xlife Sciences AG (XLS.SW) on Bullrun: market cap CHF 56.52M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerXLS.SW
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCHF
- Market capCHF 56.52M
- Financial periodFY2025
- RevenueCHF 275.31K
- Revenue growth-67.0%
- Net income-CHF 21.55M
- Free cash flow-CHF 1.28M
- Gross margin3.4%
Valuation Snapshot
latest market cap is CHF 56.52M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 275.31K | -CHF 21.55M | -CHF 1.28M | 3.4% | -3.76 | CHF 404.41K | CHF 60.00M | CHF 286.53M |
| FY2024 | CHF 834.88K | CHF 34.28M | -CHF 433.60K | 65.8% | 4.69 | CHF 99.03K | CHF 59.25M | CHF 305.26M |
| FY2023 | CHF 988.44K | CHF 14.88M | CHF 130.70K | 45.4% | 2.08 | CHF 218.71K | CHF 56.52M | CHF 268.17M |
| FY2022 | CHF 1.03M | CHF 14.31M | -CHF 4.69M | 18.1% | 2 | CHF 221.04K | CHF 60.35M | CHF 235.23M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | CHF 56.52M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CHF.
About Xlife Sciences AG
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company's project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Xlife Sciences AG's market cap?
Xlife Sciences AG's market capitalization is CHF 56.52M.
What does Xlife Sciences AG do?
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company's project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services.